Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia
The expression of apoptosis-related <i>BCL2</i> family genes, fine-tuned in normal cells, is dysregulated in many neoplasms. In acute myeloid leukemia (AML), this problem has not been studied comprehensively. To address this issue, RNA-seq data were used to analyze the expression of 26 B...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3175 |
_version_ | 1797528711186087936 |
---|---|
author | Luiza Handschuh Pawel Wojciechowski Maciej Kazmierczak Krzysztof Lewandowski |
author_facet | Luiza Handschuh Pawel Wojciechowski Maciej Kazmierczak Krzysztof Lewandowski |
author_sort | Luiza Handschuh |
collection | DOAJ |
description | The expression of apoptosis-related <i>BCL2</i> family genes, fine-tuned in normal cells, is dysregulated in many neoplasms. In acute myeloid leukemia (AML), this problem has not been studied comprehensively. To address this issue, RNA-seq data were used to analyze the expression of 26 BCL2 family members in 27 AML FAB M1 and M2 patients, divided into subgroups differently responding to chemotherapy. A correlation analysis, analysis of variance, and Kaplan-Meier analysis were applied to associate the expression of particular genes with other gene expression, clinical features, and the presence of mutations detected by exome sequencing. The expression of <i>BCL2</i> family genes was dysregulated in AML, as compared to healthy controls. An upregulation of anti-apoptotic and downregulation of pro-apoptotic genes was observed, though only a decrease in <i>BMF</i>, <i>BNIP1</i>, and <i>HRK</i> was statistically significant. In a group of patients resistant to chemotherapy, overexpression of <i>BCL2L1</i> was manifested. In agreement with the literature data, our results reveal that <i>BCL2L1</i> is one of the key players in apoptosis regulation in different types of tumors. An exome sequencing data analysis indicates that <i>BCL2</i> family genes are not mutated in AML, but their expression is correlated with the mutational status of other genes, including those recurrently mutated in AML and splicing-related. High levels of some <i>BCL2</i> family members, in particular <i>BIK</i> and <i>BCL2L13</i>, were associated with poor outcome. |
first_indexed | 2024-03-10T10:03:16Z |
format | Article |
id | doaj.art-11e3246d0b70446ca6814babd7a5aeaf |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-10T10:03:16Z |
publishDate | 2021-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-11e3246d0b70446ca6814babd7a5aeaf2023-11-22T01:45:02ZengMDPI AGCancers2072-66942021-06-011313317510.3390/cancers13133175Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic LeukemiaLuiza Handschuh0Pawel Wojciechowski1Maciej Kazmierczak2Krzysztof Lewandowski3Laboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, PolandLaboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, PolandDepartment of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, 60-569 Poznan, PolandDepartment of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, 60-569 Poznan, PolandThe expression of apoptosis-related <i>BCL2</i> family genes, fine-tuned in normal cells, is dysregulated in many neoplasms. In acute myeloid leukemia (AML), this problem has not been studied comprehensively. To address this issue, RNA-seq data were used to analyze the expression of 26 BCL2 family members in 27 AML FAB M1 and M2 patients, divided into subgroups differently responding to chemotherapy. A correlation analysis, analysis of variance, and Kaplan-Meier analysis were applied to associate the expression of particular genes with other gene expression, clinical features, and the presence of mutations detected by exome sequencing. The expression of <i>BCL2</i> family genes was dysregulated in AML, as compared to healthy controls. An upregulation of anti-apoptotic and downregulation of pro-apoptotic genes was observed, though only a decrease in <i>BMF</i>, <i>BNIP1</i>, and <i>HRK</i> was statistically significant. In a group of patients resistant to chemotherapy, overexpression of <i>BCL2L1</i> was manifested. In agreement with the literature data, our results reveal that <i>BCL2L1</i> is one of the key players in apoptosis regulation in different types of tumors. An exome sequencing data analysis indicates that <i>BCL2</i> family genes are not mutated in AML, but their expression is correlated with the mutational status of other genes, including those recurrently mutated in AML and splicing-related. High levels of some <i>BCL2</i> family members, in particular <i>BIK</i> and <i>BCL2L13</i>, were associated with poor outcome.https://www.mdpi.com/2072-6694/13/13/3175AML<i>BCL2</i> familyapoptosisgene expressionRNA-seqexome sequencing |
spellingShingle | Luiza Handschuh Pawel Wojciechowski Maciej Kazmierczak Krzysztof Lewandowski Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia Cancers AML <i>BCL2</i> family apoptosis gene expression RNA-seq exome sequencing |
title | Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia |
title_full | Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia |
title_fullStr | Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia |
title_full_unstemmed | Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia |
title_short | Transcript-Level Dysregulation of <i>BCL2</i> Family Genes in Acute Myeloblastic Leukemia |
title_sort | transcript level dysregulation of i bcl2 i family genes in acute myeloblastic leukemia |
topic | AML <i>BCL2</i> family apoptosis gene expression RNA-seq exome sequencing |
url | https://www.mdpi.com/2072-6694/13/13/3175 |
work_keys_str_mv | AT luizahandschuh transcriptleveldysregulationofibcl2ifamilygenesinacutemyeloblasticleukemia AT pawelwojciechowski transcriptleveldysregulationofibcl2ifamilygenesinacutemyeloblasticleukemia AT maciejkazmierczak transcriptleveldysregulationofibcl2ifamilygenesinacutemyeloblasticleukemia AT krzysztoflewandowski transcriptleveldysregulationofibcl2ifamilygenesinacutemyeloblasticleukemia |